Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.35 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.33 |
| ▸ | BRD7 | Q9NPI1 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | RXRA | P19793 | 1/20 | 0.31 |
| ▸ | RXRB | P28702 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.30 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2115058 | 0.83 | ACHE (0.42) | ACHEALDH1A1MAPTTSHR | |
| SCHEMBL67548 | 0.80 | ACHE (0.38) | ACHEALDH1A1MAPTLMNATSHR | |
| SCHEMBL21295672 | 0.79 | CYP2A6 (0.46) | CYP2A6 | |
| SCHEMBL28000910 | 0.79 | RAB9A (0.39) | ACHEALDH1A1MAPTTSHR | |
| SCHEMBL7702883 | 0.78 | CA1 (0.48) | ACHEADORA2AADORA1ALDH1A1LMNA | |
| SCHEMBL9646719 | 0.78 | ACHE (0.32) | ACHE | |
| SCHEMBL1070016 | 0.77 | CYP1A2 (0.38) | ACHETSHRCYP1A2CYP2A6PSMB5 | |
| SCHEMBL7138582 | 0.76 | ACHE (0.36) | ACHEALDH1A1RXRARXRBTSHR | |
| SCHEMBL2449602 | 0.76 | ALDH1A1 (0.41) | ALDH1A1CYP1A2CYP2A6 | |
| SCHEMBL1141083 | 0.75 | NPC1 (0.39) | ACHEALDH1A1MAPTLMNATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118344695-A | Hydroxyl-enriched cycloolefin copolymer long afterglow material and application thereof | 重庆理工大学 | 2024-07-16 | — | — | CN | claimed |
| CN-114989519-A | Application of cycloolefin polymer in long afterglow material | 重庆理工大学 | 2022-09-02 | — | — | CN | claimed |
| CN-104710381-A | Novel 3-hydroxy-5-arylisothiazole derivative | MOCHIDA PHARM CO LTD | 2015-06-17 | — | — | CN | claimed |
| US-6288091-B1 | COMPOUNDS SUCH AS 2,2,2-TRICHLOROETHYL N-(4-(2-AMINO-4-THIAZOLYL)-PHENYL)CARBAMATE THAT INHIBIT THE HERPES HELCASE-PRIMASE ENZYME COMPLEX | BOEHRINGER INGELHEIM LTD. (CA) | 2001-09-11 | — | — | US | claimed |
| CN-118344695-A | Hydroxyl-enriched cycloolefin copolymer long afterglow material and application thereof | 重庆理工大学 | 2024-07-16 | — | — | CN | disclosed |
| CN-117044428-A | Lateral current suppressing material, carbazole compound, hole injection layer, and organic electroluminescent element | 东曹株式会社 | 2023-11-10 | — | — | CN | disclosed |
| CN-114989519-B | Application of cycloolefin polymer in long afterglow material | 重庆理工大学 | 2023-08-25 | — | — | CN | disclosed |
| CN-114989519-A | Application of cycloolefin polymer in long afterglow material | 重庆理工大学 | 2022-09-02 | — | — | CN | disclosed |
| CN-110099878-A | Compound glass sealing material and compound glass | DIC株式会社 | 2019-08-06 | — | — | CN | disclosed |
| CN-106795092-B | Epoxy ester compound, cellulose ester resin composition, optical film and liquid crystal display device | DIC株式会社 | 2019-05-17 | — | — | CN | disclosed |
| CN-106795092-A | Epoxy ester compound, cellulose ester resin composition, optical film and liquid crystal display device | DIC株式会社 | 2017-05-31 | — | — | CN | disclosed |
| CN-104710381-A | Novel 3-hydroxy-5-arylisothiazole derivative | MOCHIDA PHARM CO LTD | 2015-06-17 | — | — | CN | disclosed |
| CN-104140445-A | Red organic electrophosphorescent material iridium metal complex, preparation method thereof, and organic electroluminescent device | OCEANS KING LIGHTING SCIENCE | 2014-11-12 | — | — | CN | disclosed |
| CN-102712610-A | Novel 3-hydroxy-5-arylisothiazole derivatives | MOCHIDA PHARM CO LTD | 2012-10-03 | — | — | CN | disclosed |
| CN-101955690-A | The manufacture method of dispersible pigment dispersion | SUMITOMO CHEMICAL CO | 2011-01-26 | — | — | CN | disclosed |
| EP-1425283-A1 | NOVEL 4-AMINOFUROPYRIMIDINES AND THE USE THEREOF | Bayer HealthCare AG (DE) | 2004-06-09 | — | — | EP | disclosed |
| WO-2003018589-A1 | NOVEL 4-AMINOFUROPYRIMIDINES AND THE USE THEREOF | BAYER HEALTHCARE AG (DE) | 2003-03-06 | — | — | WO | disclosed |
| US-6288091-B1 | COMPOUNDS SUCH AS 2,2,2-TRICHLOROETHYL N-(4-(2-AMINO-4-THIAZOLYL)-PHENYL)CARBAMATE THAT INHIBIT THE HERPES HELCASE-PRIMASE ENZYME COMPLEX | BOEHRINGER INGELHEIM LTD. (CA) | 2001-09-11 | — | — | US | disclosed |
| US-4808607-A | ATHEROSCLEROSIS, HYPERLIPOPROTEINEMIA | SANDOZ PHARM. CORP. (US) | 1989-02-28 | — | — | US | disclosed |
| US-4755606-A | Imidazolyl-3,5-di-(diphenyl-butylsilyloxy) carboxylic acid ester intermediates | SANDOZ PHARM. CORP. (US) | 1988-07-05 | — | — | US | disclosed |